NCT04213885View on ClinicalTrials.gov

Safety and Effectiveness of the PXL Platinum 330 System for Corneal Collagen Cross-Linking in Eyes With Corneal Thinning Position

PHASE2CompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

May 4, 2020

Primary Completion Date

August 5, 2024

Study Completion Date

August 5, 2024

Conditions
Keratoconus, UnstableEctasia CornealBacterial Keratitis
Interventions
COMBINATION_PRODUCT

PXL 330 Platinum device/Riboflavin

30mW, 5 sec, 5 sec off, 10 minutes of illumination

Trial Locations (1)

46220

Eye Specialists of Indiana, Indianapolis

All Listed Sponsors
lead

Eye Specialists of Indiana

OTHER

NCT04213885 - Safety and Effectiveness of the PXL Platinum 330 System for Corneal Collagen Cross-Linking in Eyes With Corneal Thinning Position | Biotech Hunter | Biotech Hunter